Literature DB >> 11464189

Primary cutaneous malignant melanoma and its precursor lesions: diagnostic and therapeutic overview.

M H Kanzler1, S Mraz-Gernhard.   

Abstract

During the past few decades, scientific data relating to melanoma have flourished. New information regarding acquired nevi, dysplastic nevi (atypical nevi), and congenital nevi has given us a better understanding of these precursor lesions and their relationships to malignant melanoma. The roles of laboratory testing, photography, and newer diagnostic tools (eg, epiluminescence) to evaluate patients for melanoma or precursor lesions have fallen under close scrutiny. Traditional surgical therapeutic interventions continue to be replaced by less aggressive protocols based on prospective randomized studies. Many new interventions such as sentinel lymph node procedures are currently being evaluated at research/referral centers around the world. We present clinicians with an evidence-based summary of the current literature with regard to primary cutaneous melanoma, its diagnosis, precursor lesions, and therapy.

Entities:  

Mesh:

Year:  2001        PMID: 11464189     DOI: 10.1067/mjd.2001.116239

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  9 in total

1.  A lesion suspected of melanoma by dermoscopy: we must trust this diagnostic tool.

Authors:  Paula Cabral de Menezes Gurfinkel; Gabriella Campos-do-Carmo; Cleide Eiko Ishida; Juan Piñeiro-Maceira; Paulo Marcos Valiante; Marcia Ramos-E-Silva
Journal:  J Dermatol Case Rep       Date:  2013-09-30

2.  Melanoma inhibitor of apoptosis protein is expressed differentially in melanoma and melanocytic naevus, but similarly in primary and metastatic melanomas.

Authors:  J Gong; N Chen; Q Zhou; B Yang; Y Wang; X Wang
Journal:  J Clin Pathol       Date:  2005-10       Impact factor: 3.411

Review 3.  Tumors of the hand.

Authors:  Andreas F Mavrogenis; Georgios N Panagopoulos; Andrea Angelini; Jan Lesenský; Christos Vottis; Panayiotis D Megaloikonomos; Zinon T Kokkalis; Vasilios Kontogeorgakos; Pietro Ruggieri; Panayiotis J Papagelopoulos
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-06-05

Review 4.  Nanoparticle-Based Combination Therapy for Melanoma.

Authors:  Hongbo Chen; Kai Hou; Jing Yu; Le Wang; Xue Chen
Journal:  Front Oncol       Date:  2022-06-28       Impact factor: 5.738

5.  Evaluation of aid to diagnosis of pigmented skin lesions in general practice: controlled trial randomised by practice.

Authors:  Dallas R English; Robert C Burton; Chris B del Mar; Robert J Donovan; Paul D Ireland; Geoff Emery
Journal:  BMJ       Date:  2003-08-16

Review 6.  [The dysplastic nevus. Separate entity, melanoma precursor or diagnostic dilemma?].

Authors:  A Roesch; M Landthaler; T Vogt
Journal:  Hautarzt       Date:  2003-09       Impact factor: 0.751

Review 7.  From melanocytes to melanomas.

Authors:  A Hunter Shain; Boris C Bastian
Journal:  Nat Rev Cancer       Date:  2016-04-29       Impact factor: 60.716

8.  Morphologic characteristics of nevi associated with melanoma: a clinical, dermatoscopic and histopathologic analysis.

Authors:  Temeida Alendar; Harald Kittler
Journal:  Dermatol Pract Concept       Date:  2018-04-30

9.  Expression levels of FBXW7 and MDM2 E3 ubiquitin ligases and their c-Myc and p53 substrates in patients with dysplastic nevi or melanoma.

Authors:  Julija Mozuraitiene; Zivile Gudleviciene; Ieva Vincerzevskiene; Aida Laurinaviciene; Justinas Pamedys
Journal:  Oncol Lett       Date:  2020-11-12       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.